A study led by researchers at the University of Texas at El Paso (UTEP) has found that people with type 2 diabetes or obesity who were prescribed GLP-1 receptor agonists (GLP-1 RAs) had substantially lower odds of developing alcohol, opioid, nicotine, and cocaine use disorders compared with similar individuals who were not taking the medications
References: Ozempic (semaglutide) injection, for subcutaneous use
Microdosing may be a fit for women who: Are in perimenopause or menopause and experiencing weight changes, increased cravings, or energy dips Want a gentle, adjustable approach to GLP-1 therapy Prefer pairing medication with lifestyle strategies (nutrition, strength training, hormone therapy) Have no major contraindications to GLP-1 medications When Were More Cautious We may recommend holding off or exploring other options if you have: A personal or family history of medullary thyroid carcinoma or MEN2 A history of pancreatitis Significant gastrointestinal disorders that may be worsened by GLP-1 use Protecting Muscle & Metabolic Health While on GLP1 One of the biggest concerns with any weight-management medication is the potential loss of lean muscle mass
If you are exploring medical options to manage your weight, you have likely heard of glucagon-like peptide-1 (GLP-1) receptor agonists
However, regular monitoring and careful management of medication interactions are essential, particularly for patients with pre-existing thyroid conditions
How to Use Quicksilver Scientific Glutathione Complex Using Quicksilver Scientific Glutathione Complex is as easy as bribing your dog with treats (but way healthier): Shake It Up: Shake the bottle like youre about to nail the perfect cocktail
